Nymox Pharmaceutical Corp Beta
Что обозначает Beta в Nymox Pharmaceutical Corp?
Beta Nymox Pharmaceutical Corp является 0.00
Какое определение для Beta?
БЕТА показывает, если акция является более или менее волатильной, чем рынок в целом. Бета меньше 1 указывает на то, что акции менее волатильные, чем рынок, а бета больше 1 указывает на то, что акции более волатильные. Волатильность измеряется как колебание цены вокруг среднего значения.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta компаний в Health Care сектор на NASDAQ по сравнению с Nymox Pharmaceutical Corp
Что делает Nymox Pharmaceutical Corp?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Компании с beta похож на Nymox Pharmaceutical Corp
- Vision Marine Technologies имеет Beta из 0.00
- Ely Gold Royalties имеет Beta из 0.00
- Glacier Lake Resources имеет Beta из 0.00
- Magnum Mining and Exploration имеет Beta из 0.00
- Africa Opportunity Fund имеет Beta из 0.00
- Fulcrum Utility Services имеет Beta из 0.00
- Nymox Pharmaceutical Corp имеет Beta из 0.00
- Gullewa имеет Beta из 0.00
- S.A.L. Steel имеет Beta из 0.00
- Andina Acquisition III имеет Beta из 0.00
- Andina Acquisition III имеет Beta из 0.00
- Brilliant Acquisition имеет Beta из 0.00
- Indokem имеет Beta из 0.00